Di Zheng

Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non–small cell lung carcinoma

Barbara Frederick, Barbara A. Helfrich, Christopher D. Coldren et al. · Molecular Cancer Therapeutics · 2007 · 273 citations

Medicine, Oncology, Pharmacology +17

Mesenchymal stromal cell apoptosis is required for their therapeutic function

Swee Heng Milon Pang, Joshua D’Rozario, Senora Mendonca et al. · Nature Communications · 2021 · 258 citations · Full text

Life Sciences, Cell Biology, Immunology +15

Cannabinoid CB1 receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behavior

C. Shen, Di Zheng, Kexin Li et al. · Nature Medicine · 2019 · 237 citations

Life Sciences, Neuroscience, Pharmacology +14

Plasma EGFR T790M ctDNA status is associated with clinical outcome in advanced NSCLC patients with acquired EGFR-TKI resistance

Di Zheng, Xue-Rui Ye, manman zhang et al. · Scientific Reports · 2016 · 226 citations · Full text

Medicine, Molecular Biology, Oncology +15

Circulating tumor DNA clearance predicts prognosis across treatment regimen in a large real-world longitudinally monitored advanced non-small cell lung cancer cohort

Yong Song, Chengping Hu, Zhanhong Xie et al. · Translational Lung Cancer Research · 2020 · 119 citations · Full text

Medicine, Molecular Medicine, Oncology +17